Study of Serum Vitamin D Level and its Relationship with Depression in Patients Visiting the Department of Psychiatry and Mental Health of Tertiary Care Hospital, Nepal: A Case-Control Study

Subedee, Shantos; Pandey, Gaurab; Poudel, Kiran; Jaishi, Krishna Prasad

doi:10.61186/rabms.10.1.4

Volume 10, Issue 1 (1-2024) Journal of Research in Applied and Basic Medical Sciences 2024, 10(1): 4-12 | Back to browse issues page

‎ 10.61186/rabms.10.1.4

Ethics code: 22(6-11-E)2/070/071

Mendeley

Zotero

RefWorks

Subedee S, Pandey G, Poudel K, Jaishi K P. Study of Serum Vitamin D Level and its Relationship with Depression in Patients Visiting the Department of Psychiatry and Mental Health of Tertiary Care Hospital, Nepal: A Case-Control Study. Journal of Research in Applied and Basic Medical Sciences 2024; 10 (1) :4-12
URL: http://ijrabms.umsu.ac.ir/article-1-283-en.html

Study of Serum Vitamin D Level and its Relationship with Depression in Patients Visiting the Department of Psychiatry and Mental Health of Tertiary Care Hospital, Nepal: A Case-Control Study

Shantos Subedee ^*

, Gaurab Pandey

, Kiran Poudel

, Krishna Prasad Jaishi

National Public Health Laboratory, Teku, Kathmandu, Nepal , shantossubedee@gmail.com

Abstract: (533 Views)

Background & Aims: An estimated 350 million individuals worldwide suffer from depression, making it a widespread ailment. The mapping of vitamin D receptors in the brain suggests that vitamin D plays a function in psychosomatic illnesses like depression. Limited information exists on vitamin D status and depression in the Nepalese population. The present study aimed to determine the level of vitamin D in patients with depression and compare it with normal individuals. Similarly, it aimed to find out how the level of vitamin D varies with the severity of depression.
Materials & Methods: The case-control study was conducted at Tribhuvan University Teaching Hospital (TUTH), in Kathmandu, Nepal. In this study, 85 depressive patients and 85 age-sex-matched healthy controls were enrolled. Vitamin D was assessed in the Department of Biochemistry with the Electro-Chemiluminescent Immune Assay (E-CLIA) method. The data were entered into the Microsoft Excel program. Statistical analyses were performed with SPSS software 17.0 version. The mean comparison, group association, and correlation were determined by using t-test, Chi-square test, and Pearson’s correlation, respectively. A probability of < 0.05 was accepted as significant.
Results: The level of vitamin D in patients with depression was found to be significantly lower than that in healthy controls. Likewise, the level of vitamin D was found to vary with the severity of depression; with severe depression, the level of vitamin D was the lowest and the result was found to be statistically significant (P < 0.05). Similarly, the level of vitamin D was found to be significantly lower in subjects having suicidal tendencies (P < 0.05).
Conclusion: The cause-and-effect link between depression and vitamin D deficiency is unclear, but their coexistence in the Nepalese community raises public health concerns. Recognizing those at risk and taking early action is crucial, as severe depression is a potential risk factor for suicidal thoughts.

Keywords: Case-Control Study, Depression, Suicidal Tendencies, Nepal, Vitamin D

Full-Text [PDF 377 kb] (234 Downloads) | | Full-Text (HTML) (18 Views)

Type of Study: biochemistry | Subject: General

References

1. Ara SK. Analysis of the prescribing pattern of antidepressants and the side effects in depression patients. J Family Med Prim Care 2022;11(11):6640-5. [DOI:10.4103/jfmpc.jfmpc_1288_21] [PMID] []

2. Luthra M. Depression: Current scenario with reference to India. Indian J Com Health 2017;29(1):01-4. [DOI:10.47203/IJCH.2017.v29i01.001]

3. Mekonen T, Chan GC, Connor JP, Hides L, Leung J. Estimating the global treatment rates for depression: A systematic review and meta-analysis. J Affective Dis 2021;295:1234-42. [DOI:10.1016/j.jad.2021.09.038] [PMID]

4. Shorey S, Ng ED, Wong CH. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta‐analysis. British J Clin Psychol 2022;61(2):287-305. [DOI:10.1111/bjc.12333] [PMID]

5. Neharshi S. Associating beck's cognitive behavior therapy with progressive muscular relaxation technique in treatment of major depression: A case report. Indian J Pos Psychol 2014;5(2):202-5. [URL]

6. World Health Organization, Depressive Disorder (Depression). Health Topics 2023. [URL]

7. Pompili M. Exploring the phenomenology of suicide. Suicide and Life-Threatening Behav 2010;40(3):234-44. [DOI:10.1521/suli.2010.40.3.234] [PMID]

8. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch General Psych 1995;52(1):11-9. [DOI:10.1001/archpsyc.1995.03950130011002] [PMID]

9. Sartorius N. Depression and diabetes. Dialogues in Clinical Neuroscience. 2022. [Google Scholar]

10. Health NIoM. Chronic illness and mental health: recognizing and treating depression. US Department of Health and Human Services, National Institutes of Health; 2021. [DOI:10.1037/e311212004-001]

11. Elliott M. Gender differences in causes of depression. Women Health Topics 2001;33(3-4):183-98. [DOI:10.1300/J013v33n03_11]

12. Anda RF, Whitfield CL, Felitti VJ, Chapman D, Edwards VJ, Dube SR, et al. Adverse childhood experiences, alcoholic parents, and later risk of alcoholism and depression. Psych Ser 2002;53(8):1001-9. [DOI:10.1176/appi.ps.53.8.1001] [PMID]

13. Bonelli R, Dew RE, Koenig HG, Rosmarin DH, Vasegh S. Religious and spiritual factors in depression: review and integration of the research. Depression Res Tmt 2012;2012. [DOI:10.1155/2012/962860] [PMID] []

14. Pratt LA, Brody DJ. Depression in the United States household population. CDC. 2008. [DOI:10.1037/e565102009-001]

15. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Br Struc Func 2008;213:93-118. [DOI:10.1007/s00429-008-0189-x] [PMID] []

16. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. British J Psych 2013;202(2):100-7. [DOI:10.1192/bjp.bp.111.106666] [PMID]

17. Vojinovic J. Vitamin D receptor agonists' anti‐inflammatory properties. Ann NY Acad Sci 2014;1317(1):47-56. [DOI:10.1111/nyas.12429] [PMID]

18. Wimalawansa SJ. Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology 2019;8(2):30. [DOI:10.3390/biology8020030] [PMID] []

19. Galliher-Beckley AJ, Williams JG, Cidlowski JA. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Bio 2011;31(23):4663-75. https://doi.org/10.1128/MCB.05866-11 [DOI:10.1128/mcb.05866-11] [PMID] []

20. Carlberg C, Polly P. Gene regulation by vitamin D3. Cri Rev Euk Gen Exp 1998;8(1). [DOI:10.1615/CritRevEukarGeneExpr.v8.i1.20] [PMID]

21. Clarke J. Regulation of immune system homeostasis by vitamin d signaling: implications for the central nervous system. McGill. 2021. [Google Scholar]

22. DeLuca G, Kimball S, Kolasinski J, Ramagopalan S, Ebers G. The role of vitamin D in nervous system health and disease. Neuropath App Neurobio 2013;39(5):458-84. [DOI:10.1111/nan.12020] [PMID]

23. Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Mol Br Res 1996;36(1):193-6. https://doi.org/10.1016/0169-328X(95)00314-I [DOI:10.1016/0169-328x(95)00314-i] [PMID]

24. Sonnenberg J, Luine V, Krey L, Christakos S. 1, 25-Dihydr oxyvitamin D3 treatment results in increased choline Acetyltransferase activity in specific brain nuclei. Endocrin 1986;118(4):1433-9. [DOI:10.1210/endo-118-4-1433] [PMID]

25. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psych 2007;64(3):327-37. [DOI:10.1001/archpsyc.64.3.327] [PMID]

26. Humble M. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy. Acta Psych Scand 2000;101:28-36. [DOI:10.1034/j.1600-0447.2000.02605.x] [PMID]

27. Drevets WC, Furey ML. Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Bio Psych 2010;67(5):432-8. [DOI:10.1016/j.biopsych.2009.11.021] [PMID] []

28. Stumpf WE, Sar M, Clark SA, DeLuca HF. Brain target sites for 1, 25-dihydroxyvitamin D3. Science 1982;215(4538):1403-5. [DOI:10.1126/science.6977846] [PMID]

29. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophy 2012;523(1):123-33. [DOI:10.1016/j.abb.2012.04.001] [PMID]

30. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroana 2005;29(1):21-30. [DOI:10.1016/j.jchemneu.2004.08.006] [PMID]

31. Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P. 1, 25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991;28(1):110-4. [DOI:10.1002/jnr.490280111] [PMID]

32. Brown J, Bianco JI, McGrath JJ, Eyles DW. 1, 25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Let 2003;343(2):139-43. https://doi.org/10.1016/S0304-3940(03)00303-3 [DOI:10.1016/s0304-3940(03)00303-3] [PMID]

33. Naveilhan P, Neveu I, Wion D, Brachet P. 1, 25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neurorep 1996;7(13):2171-5. [DOI:10.1097/00001756-199609020-00023] [PMID]

34. Neveu I, Naveilhan P, Baudet C, Brachet P, Metsis M. 1, 25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neurorep 1994;6(1):124-6. [DOI:10.1097/00001756-199412300-00032] [PMID]

35. Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé AA. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Intl J Neuropsychopharm 2003;6(3):225-31. https://doi.org/10.1017/S1461145703003468 [DOI:10.1017/s1461145703003468] [PMID]

36. Pae C-U, Marks DM, Han C, Patkar AA, Steffens D. Does neurotropin-3 have a therapeutic implication in major depression? Intl J Neurosci 2008;118(11):1515-22. [DOI:10.1080/00207450802174589] [PMID]

37. Shoval G, Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eu Neuropsychopharma 2005;15(3):319-29. [DOI:10.1016/j.euroneuro.2004.12.005] [PMID]

38. Zhang X, Zhang Z, Xie C, Xi G, Zhou H, Zhang Y, et al. Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog Neuro Psychopharmaco Bio Psych 2008;32(3):886-90. [DOI:10.1016/j.pnpbp.2008.01.004] [PMID]

39. Zhang X, Zhang Z, Sha W, Xie C, Xi G, Zhou H, et al. Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psych Res 2009;170(2-3):273-5. [DOI:10.1016/j.psychres.2009.01.011] [PMID]

40. Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteopo Intl 2004;15:56-61. [DOI:10.1007/s00198-003-1491-3] [PMID]

41. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 2000;72(2):472-5. [DOI:10.1093/ajcn/72.2.472] [PMID]

42. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PV, Sarma KV, et al. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr 2007;85(4):1062-7. [DOI:10.1093/ajcn/85.4.1062] [PMID]

43. Shrestha S, Shrestha L, Jha D. Vitamin D status among individuals attended in health home care Centre, Lalitpur, Nepal. Nepal Med Col J 2012;14(2):84-7. [DOI:10.3126/jnps.v32i1.5378]

44. Mithal A, Wahl DA, Bonjour J-P, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteopo Intl 2009;20:1807-20. [DOI:10.1007/s00198-009-0954-6] [PMID]

45. Marwaha R, Tandon N, Garg M, Kanwar R, Narang A, Sastry A, et al. Vitamin D status in healthy Indians aged 50 years and above. Asso Phys India 2011;59:706-9. [DOI:10.1007/s00198-010-1507-8] [PMID]

46. Sherchand O, Sapkota N, Chaudhari RK, Khan SA, Baranwal JK, Niraula A, et al. Gender differences in the prevalence of depression among the working population of Nepal. Psych J 2018;2018:1-8. [DOI:10.1155/2018/8354861] [PMID] []

47. Ganji V, Milone C, Cody MM, McCarty F, Wang YT. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Intl Arch Med 2010;3:1-8. [DOI:10.1186/1755-7682-3-29] [PMID] []

48. Lapid MI, Cha SS, Takahashi PY. Vitamin D and depression in geriatric primary care patients. Clin Interv Aging 2013:509-14. https://doi.org/10.2147/CIA.S42838 [DOI:10.2147/cia.s42838] [PMID] []

49. Stewart R, Hirani V. Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychos Med 2010;72(7):608-12. https://doi.org/10.1097/PSY.0b013e3181e9bf15 [DOI:10.1097/psy.0b013e3181e9bf15] [PMID]

50. Khattri J, Godar S, Subedi A. A study of vitamin D among patients presenting in the Psychiatric OPD of Manipal Teaching Hospital, Pokhara. Kathmandu Univ Med J 2019;68(4):293-7. [Google Scholar]

51. Tariq MM, Streeten EA, Smith HA, Sleemi A, Khabazghazvini B, Vaswani D, et al. Vitamin D: a potential role in reducing suicide risk? Intl J Adol Med Health 2011;23(3). [DOI:10.1515/ijamh.2011.038] [PMID]

52. Grudet C, Malm J, Westrin Å, Brundin L. Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. Psychoneuroendocrin 2014;50:210-9 [DOI:10.1016/j.psyneuen.2014.08.016] [PMID]

53. Wang Y, Chiang Y-H, Su T-P, Hayashi T, Morales M, Hoffer B, et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharma 2000;39(5):873-80. https://doi.org/10.1016/S0028-3908(99)00255-5 [DOI:10.1016/s0028-3908(99)00255-5] [PMID]

54. Riaz S, Malcangio M, Miller M, Tomlinson D. A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 1999;42:1308-13. [DOI:10.1007/s001250051443] [PMID]

55. Brewer LD, Thibault V, Chen K-C, Langub MC, Landfield PW, Porter NM. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci Res 2001;21(1):98-108. https://doi.org/10.1523/JNEUROSCI.21-01-00098.2001 [DOI:10.1523/jneurosci.21-01-00098.2001] [PMID] []

56. de Viragh PA, Haglid K, Celio M. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Pro Ntl Acad Sci 1989;86(10):3887-90. [DOI:10.1073/pnas.86.10.3887] [PMID] []

57. Garcion E, Nataf S, Berod A, Darcy F, Brachet P. 1, 25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Mol Br Res 1997;45(2):255-67. https://doi.org/10.1016/S0169-328X(96)00260-4 [DOI:10.1016/s0169-328x(96)00260-4] [PMID]

58. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neurosci 2003;118(3):641-53. https://doi.org/10.1016/S0306-4522(03)00040-X [DOI:10.1016/s0306-4522(03)00040-x] [PMID]

59. Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteo 2007;7(5):769-80. [DOI:10.1002/pmic.200600392] [PMID]

60. Newmark HL, Newmark J. Vitamin D and Parkinson's disease-a hypothesis. Mov Dis 2007;22(4):461-8. [DOI:10.1002/mds.21317] [PMID]

61. Tariq MM, Streeten EA, Smith HA, Sleemi A, Khabazghazvini B, Vaswani D, et al. Vitamin D: a potential role in reducing suicide risk? De Gruyter 2011. [DOI:10.1515/ijamh.2011.038] [PMID]

62. Umhau JC, George DT, Heaney RP, Lewis MD, Ursano RJ, Heilig M, et al. Low vitamin D status and suicide: a case-control study of active duty military service members. PLoS One 2013;8(1):e51543. [DOI:10.1371/journal.pone.0051543] [PMID] []